Real life effectiveness and cost impact evaluation of fixed dose combination fluticasone propionate/formoterol (Flutiform®) compared to fluticasone propionate/salmeterol (Seretide®) (eFFectiveness)

02/03/2016
23/04/2024
EU PAS number:
EUPAS12631
Study
Finalised
Documents
Study protocol
Initial protocol
English (1.16 MB - PDF) View document
Study results
Study results
English (1.21 MB - PDF) View document
Study report
Other information
ENCePP Seal
Conflicts of interest of investigators
English (95.86 KB - PDF) View document
Composition of steering group and observers
English (107.4 KB - PDF) View document